LISA MINER: Open Payments
NPI 1386692101 · SEQUIM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$532 in 27 payments from 9 companies in 2025. Trend: 2023 $802 · 2024 $528 · 2025 $532
Food & beverage: $532
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $147 |
| ABBVIE INC. | 5 | $120 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 4 | $64 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Organogenesis Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $15 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, Zoryve, RINVOQ, SIMPLIMAX, Xolair.
Industry payments across WA — which companies pay providers there.
